A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells

6.8K views

⸱

DOI:

10.3791/55794

⸱

June 14th, 2017

 ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

Marrow stromal cells (MSCs) with neural potential exist within the bone marrow. Our protocol enriches this population of cells via hypoxic preconditioning and thereafter directs them to become mature Schwann cells.

Abstract

This manuscript describes a means to enrich for neural progenitors from the marrow stromal cell (MSC) population and thereafter to direct them to the mature Schwann cell fate. We subjected rat and human MSCs to transient hypoxic conditions (1% oxygen for 16 h) followed by expansion as neurospheres upon low-attachment substratum with epidermal growth factor (EGF)/basic fibroblast growth factor (bFGF) supplementation. Neurospheres were seeded onto poly-D-lysine/laminin-coated tissue culture plastic and cultured in a gliogenic cocktail containing β-Heregulin, bFGF, and platelet-derived growth factor (PDGF) to generate Schwann cell-like cells (SCLCs). SCLCs were directed to fate commitment via coculture for 2 weeks with purified dorsal root ganglia (DRG) neurons obtained from E14-15 pregnant Sprague Dawley rats. Mature Schwann cells demonstrate persistence in S100β/p75 expression and can form myelin segments. Cells generated in this manner have potential applications in autologous cell transplantation following spinal cord injury, as well as in disease modeling.

Introduction

The transplantation of neural progenitors and their derivatives demonstrates promise as a treatment strategy following traumatic nerve injury1,2 and neurodegeneration3,4. Prior to clinical application, it is essential to ensure: i) a method for accessing and expanding upon an autologous source of stem/progenitor cells and ii) a means to direct them to relevant, mature cell types3. Our interest in cell therapy for spinal cord injury led us to seek a robust, autologous cell source of neural progenitors from adult tissues.

Access restricted. Please log in or start a trial to view this content.

Protocol

All procedures involving animals were performed in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the Committee on Use of Live Animals for Teaching and Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong. Human bone marrow samples were obtained from the iliac crest of healthy donors after obtaining informed consent. Protocols were approved by the Institutional Review Board, The University of Hong Kong.

1. Preparation of Rat MSC Cultures

  1. Harvest of MSCs from the femur
    1. Autoclave all dissection tools (i.e., fine dissecting scis....

Access restricted. Please log in or start a trial to view this content.

Results

An overview of the key stages in our protocol is illustrated in Figure 1. In summary, rat and human MSCs are selected for by adherence to tissue culture plastic. Expanded MSCs are preconditioned with hypoxia and are then subject to neurosphere-forming conditions. Neurospheres are plated and allowed to differentiate into SCLCs. SCLCs are cocultured with purified DRG neurons to generate fate-committed Schwann cells.

Access restricted. Please log in or start a trial to view this content.

Discussion

It is essential to preserve the "stemness" of MSCs prior to the enrichment of neural progenitors via hypoxic preconditioning and neurosphere culture. From our experience, multipotent MSCs can be reliably identified by their elongated fibroblast-like morphology. In contrast, MSCs that have adopted a more flattened, quadrangular morphology, with prominent cytoskeletal stress fibers, do not readily adopt neural cell fates and should be discarded. In general, we do not utilize MSCs with passage numbers greater than e.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

All authors of this manuscript have no disclosures to declare.

Acknowledgements

The authors would like to acknowledge Dr. Nai-Sum Wong for providing the hypoxia chamber apparatus and Ms. Alice Lui for the technical support.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
αMEMSigmaaldrichM4526
DMEM/F12Thermofisher scientific12400-024
Neurobasal mediumThermofisher scientific21103-049
FBSBioseraFB-1280/500
B27Thermofisher scientific17504-001
Epidermal growth factor (EGF)Thermofisher scientificPHG0313
Basic fibroblast growth factor (bFGF) Peprotech100-18B/100UG
Nerve growth factor (NGF) MilliporeNC011
Platelet-derived growth factor-AA (PDGF-AA)Peprotech100-13A
Heregulin beta-3, EGF domain (β-Her)Millipore01-201
UridineSigmaaldrichU3003
5-Fluro-2' - deoxyuridine (FDU)SigmaaldrichF0503
Poly-D-lysine (PDL)SigmaaldrichP7886-1G
LamininThermofisher scientific23017015
GlutaMAXThermofisher scientific35050061
Penicillin / streptomycin (P/S)Thermofisher Scientific15140-122
TrypLE ExpressThermofisher Scientific12604-013
10 cm plate for adherent cultureTPP93100Used for selection of MSCs by tissue culture adherence
6-well plate for adherent cultureTPP92006Used for expansion of MSCs following passaging
UltraLow 6-well plate for non-adherent cultureCorning3471Used for neural progenitor enrichment
anti-human CD90(Thy-1)BD Biosciences555593
anti-human CD73BD Biosciences550256
anti-human/rat STRO-1R&D SystemsMAB1038
anti-human nestinR&D SystemsMAB1259
anti-human CD45BD Biosciences555480
anti-rat CD90(Thy-1)BD Biosciences554895
anti-rat CD73BD Biosciences551123
anti-rat nestinBD BiosciencesMAB1259
anti-rat CD45BD Biosciences554875
Anti-S100βDakoZ031101
Anti-p75MilliporeMAB5386
Anti-GFAPSigmaaldrichG3893
Anti-Class III-beta tubulin (Tuj-1)CovanceMMS-435P
Anti-Human nucleiMilliporeMAB1281
Hypoxia chamberBillups-RothenbergMIC-101
HEPES bufferSigmaaldrichH4034-100G

References

  1. Wiliams, R. R., Bunge, M. B. Schwann cell transplantation: a repair strategy for spinal cord injury? Prog Brain Res. 201, 295-312 (2012).
  2. Kanno, H., Pearse, D. D., Ozawa, H., Itoi, E., Bunge, M. B. Schwann cell transplantation....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Marrow Stromal CellsNeural ProgenitorsSchwann Cell DifferentiationNeurosphere CultureDorsal Root GangliaCo-culture TechniqueGlial Induction MediumS100 Beta ExpressionMyelin Segment Formation